City

Clinical trials near Québec, Canada

Active studies with a listed research site in Québec, Canada.

35active studies

22recruiting now

21countries represented

243largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Osteoarthritis, Overweight or ObesityCondition

Eloralintide, PlaceboTreatment

Argentina, Belgium152 locations

Eli Lilly and CompanySponsor

Updated 2026-09-08 · NCT07353931See eligibility →

Recruiting nowPhase 3

A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight

Urinary Incontinence,StressCondition

Orforglipron, PlaceboTreatment

Canada, China136 locations

Eli Lilly and CompanySponsor

Updated 2026-09-08 · NCT07202884See eligibility →

Recruiting nowPhase 3

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Sleep Apnea, Obstructive, ObesityCondition

Eloralintide, PlaceboTreatment

Australia, Brazil115 locations

Eli Lilly and CompanySponsor

Updated 2026-09-08 · NCT07369011See eligibility →

Recruiting nowPhase 3

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee

OsteoarthritisCondition

Orforglipron, PlaceboTreatment

Canada, China88 locations

Eli Lilly and CompanySponsor

Updated 2026-09-08 · NCT07153471See eligibility →

Recruiting nowPhase 3

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Type 2 DiabetesCondition

Placebo, SurvodutideTreatment

Australia, Canada121 locations

Boehringer IngelheimSponsor

Updated 2026-09-03 · NCT07754461See eligibility →

Recruiting nowPhase 2

A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight

Obesity, OverweightCondition

BI 3034701, Placebo matching BI 3034701Treatment

Australia, Canada54 locations

Boehringer IngelheimSponsor

Updated 2026-09-03 · NCT07662122See eligibility →

Recruiting nowPhase 3

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Obesity, OverweightCondition

NNC0487-0111, Placebo (matched to NNC0487-0111)Treatment

Australia, Bulgaria81 locations

Novo Nordisk A/SSponsor

Updated 2026-08-17 · NCT07509307See eligibility →

Recruiting nowPhase 3

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Obesity or OverweightCondition

Placebo, EnicepatideTreatment

Argentina, Australia195 locations

Hoffmann-La RocheSponsor

Updated 2026-08-14 · NCT07351045See eligibility →

Recruiting nowPhase 3

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Obesity or Overweight, Type 2 Diabetes MellitusCondition

Placebo, EnicepatideTreatment

Argentina, Australia193 locations

Hoffmann-La RocheSponsor

Updated 2026-08-14 · NCT07351058See eligibility →

Recruiting nowNot applicable

Incretin-based Therapies, Nutrition, and Physical Activity

Obesity & Overweight, Cardiometabolic ConditionsCondition

Intervention, Incretin-Based TreatmentTreatment

Canada2 locations

Laval UniversitySponsor

Updated 2026-07-16 · NCT07409831See eligibility →

Recruiting nowPhase 3

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Obesity, Knee Osteoarthritis (OA)Condition

NNC0487-0111, Placebo (matched to NNC0487-0111 )Treatment

Australia, Bulgaria82 locations

Novo Nordisk A/SSponsor

Updated 2026-07-09 · NCT07481630See eligibility →

Recruiting nowNot applicable

Egg Intake, Metabolic Outcomes and Choline Levels

Obesity and Obesity-related Medical ConditionsCondition

3 whole eggsTreatment

Canada1 locations

University of GuelphSponsor

Updated 2026-05-12 · NCT06687122See eligibility →

Recruiting nowNot applicable

Effects of Cranberry on Gut and Metabolic Health

Overweight/Obesity, Metabolic SyndromeCondition

Cranberry beverage, Placebo beverageTreatment

Canada1 locations

Laval UniversitySponsor

Updated 2026-03-10 · NCT07460856See eligibility →

Recruiting nowPhase 1

Safety Follow-up Study of Participants Dosed With INV-347 in Study INV-CL-108

ObesityCondition

INV-347Treatment

Canada1 locations

Novo Nordisk A/SSponsor

Updated 2026-03-06 · NCT07153172See eligibility →

Recruiting nowNot applicable

Management of Sleeve Gastrectomy Failure Using Single-anastomosis Metabolic Surgery

Obesity, Obesity, MorbidCondition

Standard duodenal switch, Single-anastomosis duodenal switchTreatment

Canada1 locations

Laval UniversitySponsor

Updated 2025-12-08 · NCT05242835See eligibility →

Recruiting nowNot applicable

Influence of FreeO2 on Percentage of Time Within Oxygen Saturation Target Using Noninvasive Ventilation (NIV) and Continuous Positive Airway Pressure (CPAP) for Patients Admitted for AECOPD or Bariatric Surgery

COPD Exacerbation, Oxygen ToxicityCondition

Washout period, NIV - FreeO2Treatment

Canada1 locations

François LelloucheSponsor

Updated 2025-09-04 · NCT04136717See eligibility →

Recruiting nowPhase 4

Improving Efficacity of Sleeve Gastrectomy With Naltrexone/Bupropion Extended-release Tablet

Obesity; Drug, Obesity, MorbidCondition

Naltrexone/Bupropion, PlaceboTreatment

Canada1 locations

Laval UniversitySponsor

Updated 2025-08-08 · NCT06620562See eligibility →

Recruiting nowNot applicable

Bone Health After Bariatric Surgery in Patients With Type 2 Diabetes

Bariatric Surgery, Bone HealthCondition

Bariatric surgeryTreatment

Canada3 locations

CHU de Quebec-Universite LavalSponsor

Updated 2025-06-10 · NCT03455868See eligibility →

Recruiting nowNot applicable

Bone and Muscle Health Following Sleeve Gastrectomy in Men, Premenopausal and Postmenopausal Women

Bariatric Surgery, Bone HealthCondition

Bariatric surgeryTreatment

Canada1 locations

CHU de Quebec-Universite LavalSponsor

Updated 2025-06-10 · NCT06547515See eligibility →

Recruiting nowNot applicable

Healthy for my Baby- RCT of a Lifestyle Intervention for Overweight Women in Preconception

Overweight and Obesity, Pregnancy ComplicationsCondition

Healthy for my Baby, Usual CareTreatment

Canada2 locations

Université de SherbrookeSponsor

Updated 2025-04-02 · NCT04242069See eligibility →

Recruiting nowNot applicable

BariaPSY: the Data Bank

Bariatric Surgery Candidate, ObesityCondition

Intervention not listedTreatment

Canada1 locations

Laval UniversitySponsor

Updated 2024-10-09 · NCT05602805See eligibility →

Recruiting nowNot applicable

Optimal Cardiopulmonary Bypass and Anticoagulation Management Strategies in Obese Patients Undergoing Cardiac Surgery

Cardiopulmonary Bypass, ObesityCondition

Heparin, cardiopulmonary bypass pump flow rateTreatment

Canada1 locations

Laval UniversitySponsor

Updated 2023-03-10 · NCT03302195See eligibility →

Opening soonPhase 3

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Obesity or Overweight, Diabetes Mellitus, Type 2Condition

AZD6234, PlaceboTreatment

Argentina, Australia218 locations

AstraZenecaSponsor

Updated 2026-08-25 · NCT07784270See eligibility →

Opening soonNot applicable

Investigating Metabolic, Brain, and Cognitive Alterations Through Bariatric Surgery

Obesity, MorbidCondition

Sleeve GastrectomyTreatment

Canada1 locations

Laval UniversitySponsor

Updated 2026-07-16 · NCT07704229See eligibility →

Opening soonNot applicable

OBEDIAM: Therapeutic Patient Education in Adults Living With Obesity, Diabetes, and Metabolic Disorders

Obesity (BMI>30)Condition

Therapeutic patient educationTreatment

Canada1 locations

CHU de Quebec-Universite LavalSponsor

Updated 2026-06-25 · NCT07668661See eligibility →

Opening soonNot applicable

Obesity Medicine Bank of the Quebec Heart and Lung Institute - Laval University (IUCPQ-ULaval)

Obesity, Metabolic AbnormalitiesCondition

Behavioral and Pharmacological TreatmentsTreatment

Canada1 locations

Institut universitaire de cardiologie et de pneumologie de Québec, University LavalSponsor

Updated 2026-03-16 · NCT07472608See eligibility →

Opening soonNot applicable

Digital Preparation for Bariatric Surgery: Feasability Pilot Trial

Obesity, Bariatric Surgery PatientsCondition

Acces to Precare online platformTreatment

Canada1 locations

Laval UniversitySponsor

Updated 2025-10-01 · NCT07201870See eligibility →

Opening soonNot applicable

Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

Metabolic Associated Fatty Liver Disease, Metabolic Associated-dysfunction Steatohepatitis (MASH)Condition

semaglutide, DietTreatment

Canada1 locations

Institut universitaire de cardiologie et de pneumologie de Québec, University LavalSponsor

Updated 2025-01-08 · NCT06764056See eligibility →

Active, not recruitingNot applicable

Effects of Blueberry on Gut Microbiota and Metabolic Syndrome

Gut Microbiota, Metabolic SyndromeCondition

50 g of blueberry powder, taken daily for 8 weeks, 50g of placebo blueberry powder, taken daily for 8 weeksTreatment

Canada1 locations

Laval UniversitySponsor

Updated 2026-09-08 · NCT03266055See eligibility →

Active, not recruitingNot applicable

Effect of Raspberry on Gut Microbiota and Metabolic Syndrome

Gut Microbiota, Metabolic SyndromeCondition

Raspberry supplementTreatment

Canada1 locations

Laval UniversitySponsor

Updated 2026-09-08 · NCT03620617See eligibility →

Active, not recruitingPhase 3

A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight

Obesity, OverweightCondition

RetatrutideTreatment

Argentina, Canada35 locations

Eli Lilly and CompanySponsor

Updated 2026-06-09 · NCT07357415See eligibility →

Active, not recruitingPhase 3

A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity

ObesityCondition

Cagrilintide, SemaglutideTreatment

Belgium, Canada36 locations

Novo Nordisk A/SSponsor

Updated 2026-01-20 · NCT06780449See eligibility →

Active, not recruitingNot applicable

Standard Versus "Single Loop" Bypass After Parietal Gastrectomy

Obesity, Morbid, ObesityCondition

Standard duodenal switch, Single-anastomosis duodenal switchTreatment

Canada1 locations

Laval UniversitySponsor

Updated 2025-12-08 · NCT07115836See eligibility →

Active, not recruitingPhase 3

Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

ObesityCondition

Maridebart Cafraglutide, PlaceboTreatment

Argentina, Australia243 locations

AmgenSponsor

Updated 2025-10-20 · NCT06858839See eligibility →

Active, not recruitingNot applicable

Fit-for-Fertility Multicenter Randomized Controlled Trial

Obesity, Infertility, FemaleCondition

Fit-For-Fertility program, Standard of careTreatment

Canada5 locations

Université de SherbrookeSponsor

Updated 2025-03-19 · NCT03908099See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Québec, Canada

Current studies

Related cities